Mandate

Vinge advises RNB Retail and Brands

March 25, 2009

Vinge has advised RNB Retail and Brands AB (publ) (”RNB”) in connection with the sale of the operations of NK in Stockholm and NK in Gothenburg to Åhléns AB.

RNB’s operations at NK Stockholm and NK Gothenburg include distribution of nationally and internationally renowned brands within clothing, confectionery, accessories, jewellery and cosmetics. The operations in Stockholm comprise approximately 7000 square metres divided between 32 stores and, in Gothenburg, by approximately 5000 square metres divided between 20 stores.

The transaction will formally occur through the transfer of all shares in RNB’s wholly-owned subsidiary, Departments & Stores Europe AB. The sale of RNB is subject to the approval of the Swedish Competition Authority and the approval of the sale at RNB’s extraordinary general meeting.

Vinge’s team included partners Malin Leffler and Ola Sandersson and associates Jonas Bergström, Dain Nevonen, Charlotta Järnstedt and Joacim Rydergård

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026